Intrinsic Value of S&P & Nasdaq Contact Us

Hepion Pharmaceuticals, Inc. HEPA OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$70.00
+145733.3%

Hepion Pharmaceuticals, Inc. (HEPA) has 18 known insider and institutional holders on record. The largest holder is SYNERGY PHARMACEUTICALS, INC. with 9,000,000 shares. Other notable holders include Garlikov Donald E and Cavan John T.

HEPA Insider Ownership

Top Holder
SYNERGY PHARMACEUTICALS, INC.
9,000,000 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Synergy Pharmaceuticals, Inc. 10 Percent Owner 9,000,000 2013-10-07
100%
2 Garlikov Donald E 10 Percent Owner 3,320,000 2019-04-02
37%
3 Cavan John T Chief Financial Officer 1,581,060 2021-05-20
18%
4 Sapirstein James Chief Executive Officer 492,819 2018-01-05
5%
5 Mcguigan Christopher Director 415,234 2014-12-04
5%
6 Lippa Arnold Director 291,110 2021-05-20
3%
7 Adams Thomas Phd Director 291,050 2021-05-20
3%
8 Hornung William Karl Chief Financial Officer 165,000 2015-06-08
2%
9 Jacob Gary S Director 102,120 2024-02-21
1%
10 Brancaccio John P Chairman 99,563 2024-02-21
1%
11 Block Timothy M. Director 99,562 2024-02-21
1%
12 Lbiati Kaouthar Director 88,000 2024-02-21
1%
13 Howson Tamar D Director 80,000 2017-04-11
1%
14 Sullivan-bolyai John Z Chief Medical Officer 58,681 2017-07-07
1%
15 Foster Robert T CEO and Director 50,470 2023-09-19
1%
16 Purcell Michael J. Director 50,000 2024-03-07
1%
17 Denoyer Bernard Chief Financial Officer 40,000 2014-04-04
0%
18 Wijngaard Peter Director 7,001 2023-11-28
0%

No ownership data available for HEPA.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message